PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 5 filers reported holding PACIRA PHARMACEUTICALS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $240 | -59.9% | 7,749 | -48.2% | 0.05% | -58.2% |
| Q2 2023 | $598 | -65.0% | 14,953 | -64.1% | 0.11% | -67.6% |
| Q1 2023 | $1,709 | +4.5% | 41,688 | -0.5% | 0.34% | -4.2% |
| Q4 2022 | $1,635 | -99.9% | 41,918 | -3.4% | 0.35% | -33.6% |
| Q3 2022 | $2,299,000 | +24.5% | 43,378 | +36.2% | 0.53% | +28.1% |
| Q2 2022 | $1,847,000 | +689.3% | 31,844 | +932.2% | 0.42% | +845.5% |
| Q1 2022 | $234,000 | – | 3,085 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tamarack Advisers, LP | 360,000 | $21,845,000 | 6.19% |
| Gagnon Advisors, LLC | 213,217 | $12,938,000 | 4.92% |
| GAGNON SECURITIES LLC | 499,333 | $30,300,000 | 4.30% |
| Spyglass Capital Management LLC | 2,117,673 | $128,500,000 | 2.86% |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | 646,530 | $39,231,000 | 2.30% |
| Paulson & Co. | 1,273,161 | $77,255,000 | 1.85% |
| MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 212,112 | $12,871,000 | 1.44% |
| Tygh Capital Management, Inc. | 152,332 | $9,244,000 | 1.26% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,147,000 | $69,600,000 | 1.24% |
| Rock Springs Capital Management LP | 1,025,000 | $62,197,000 | 1.23% |